Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-12
2005-07-12
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S356100, C548S359100
Reexamination Certificate
active
06916838
ABSTRACT:
Tricyclic derivatives of 1-benzylpyrazole-3-carboxylic acidimg id="CUSTOM-CHARACTER-00001" he="279.40mm" wi="215.90mm" file="US06916838-20050712-P00900.TIF" alt="custom character" img-content="character" img-format="tif" ?which are antagonists of the cannabinoid CB2receptors; their method of preparation and pharmaceutical compositions containing them.
REFERENCES:
patent: 5624941 (1997-04-01), Barth et al.
patent: 5696143 (1997-12-01), Talley et al.
patent: 5925768 (1999-07-01), Barth et al.
patent: 5948777 (1999-09-01), Bender et al.
patent: 5990170 (1999-11-01), Della Valle et al.
patent: 0656354 (1995-06-01), None
patent: 1382773 (1975-02-01), None
patent: WO 96/09304 (1996-03-01), None
Barth Francis
Millan Joseph
Oustric Didier
Rinaldi Murielle
Vernhet Martine
Alexander Michael D.
Bender Kelly L.
Darkes Paul R.
Sanofi-Aventis
Shameem Golam M M
LandOfFree
1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3406330